Boxer Capital
Life sciences-focused investment firm with expertise in biotechnology and pharmaceutical investments. Known for deep scientific due diligence and hands-on approach to portfolio company development. Part of Tavistock Group.
Website
https://www.boxercap.comLocation
San Diego, USA
Founded
2005
AUM
$1.5B+
Investment Range
$5M - $75M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
Boxer Capital invests in biotechnology and pharmaceutical companies across all stages, from early-stage therapeutics to late-stage clinical assets. They leverage deep scientific expertise to identify companies with differentiated approaches and strong clinical development potential.
Team
Partners / Managing Directors (Health & Bio Focus)
- Aaron Davis - Managing Partner
- Joe McCracken, PhD - Partner
Other Key Team Members
- Scientific advisory team with drug development expertise
Focus Areas
- Therapeutics
- Oncology
- Immunology
- Neuroscience
- Rare Diseases
- Late-Stage Clinical Assets
- Public Biotech
Notable Exits
- Multiple biotech investments with successful exits through M&A and IPO
- Portfolio includes both public and private investments